| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,597 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,596 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,071 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,375 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,033 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
608 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7589059 |
Delivery of molecules and complexes to mammalian cells in vivo |
Sep. 15, 2009 |
| 7589058 |
Ghrelin analogs |
Sep. 15, 2009 |
| 7588912 |
Compositions and methods for preventing and treating anthrax diseases |
Sep. 15, 2009 |
| 7588763 |
Methods for the prevention against or treatment of diabetes with ETXB and/or insulin |
Sep. 15, 2009 |
| 7585847 |
Immunostimulatory nucleic acids for the treatment of asthma and allergy |
Sep. 8, 2009 |
| 7585838 |
Methods of treating fibromyalgia caused by small intestinal bacterial overgrowth |
Sep. 8, 2009 |
| 7585837 |
Reversible pegylated drugs |
Sep. 8, 2009 |
| 7585836 |
Bi-lateral local renal delivery for treating congestive heart failure and for BNP therapy |
Sep. 8, 2009 |
| 7585835 |
GASP1: a follistatin domain containing protein |
Sep. 8, 2009 |
| 7585834 |
Transporters comprising spaced arginine moieties |
Sep. 8, 2009 |
| 7585509 |
Erb-2 receptor targeting peptide |
Sep. 8, 2009 |
| 7585506 |
Compositions and methods for the therapy and diagnosis of lung cancer |
Sep. 8, 2009 |
| 7585495 |
Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom |
Sep. 8, 2009 |
| RE40911 |
Canine erythropoietin gene and recombinant protein |
Sep. 8, 2009 |
| 7582607 |
Muteins of fibroblast growth factor 21 |
Sep. 1, 2009 |
| 7582603 |
Method for treating or inhibiting intestinal inflammation |
Sep. 1, 2009 |
| 7582602 |
Hirulog-like peptide and gene therapy |
Sep. 1, 2009 |
| 7582601 |
Use of tryptophan rich peptides |
Sep. 1, 2009 |
| 7582312 |
Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
Sep. 1, 2009 |
| 7582311 |
Injection vehicle for polymer-based formulations |
Sep. 1, 2009 |
| 7579314 |
Use of RGD-enriched gelatine-like proteins for inhibition of cancer metastasis |
Aug. 25, 2009 |
| 7579313 |
Transglutaminase inhibitors and methods of use thereof |
Aug. 25, 2009 |
| 7579013 |
Formulations for coated microprojections containing non-volatile counterions |
Aug. 25, 2009 |
| RE40876 |
Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagonlike peptide-1 and agonists thereof |
Aug. 18, 2009 |
| 7576066 |
Nucleic acid compositions for stimulating immune responses |
Aug. 18, 2009 |
| 7576059 |
Peptide derivatives |
Aug. 18, 2009 |
| 7576058 |
Method for importing biologically active molecules into cells |
Aug. 18, 2009 |
| 7576056 |
Peptides and compounds that bind to a receptor |
Aug. 18, 2009 |
| 7576055 |
Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
Aug. 18, 2009 |
| 7576054 |
Compositions and methods for treating bacteria |
Aug. 18, 2009 |
| 7576053 |
Methods and compositions for treating degenerative bone disorders |
Aug. 18, 2009 |
| 7576052 |
Methods and compositions for modulating adipocyte function |
Aug. 18, 2009 |
| 7576051 |
Wound dressing for accelerating epidermal regeneration |
Aug. 18, 2009 |
| 7576050 |
GLP-1 exendin-4 peptide analogs and uses thereof |
Aug. 18, 2009 |
| 7575856 |
Compositions and methods for the evaluation and resuscitation of cadaveric hearts for transplant |
Aug. 18, 2009 |
| 7575755 |
Immunogenic compositions and uses thereof |
Aug. 18, 2009 |
| 7575741 |
Methods of treating cutaneous ulcers and grafts using IL-23 |
Aug. 18, 2009 |
| 7572769 |
Fibrin adhesive granulate and method for its preparation |
Aug. 11, 2009 |
| 7572768 |
Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
Aug. 11, 2009 |
| 7572766 |
IFBMs to promote the specific attachment of target analytes to the surface of orthopedic implants |
Aug. 11, 2009 |
| 7572765 |
Conformationally constrained parathyroid hormone (PTH) analogs |
Aug. 11, 2009 |
| 7572764 |
Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds |
Aug. 11, 2009 |
| 7572763 |
Follistatin domain containing proteins |
Aug. 11, 2009 |
| 7572762 |
Materials and methods relating to the induction of apoptosis in target cells |
Aug. 11, 2009 |
| 7572599 |
Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
Aug. 11, 2009 |
| 7572465 |
Isolated material having an anti-organotrophic effect |
Aug. 11, 2009 |
| 7572440 |
Method for repairing a defect in an intervertebral disc |
Aug. 11, 2009 |
| 7572436 |
Thionin as an antineoplastic and immunostimulant |
Aug. 11, 2009 |
| 7569748 |
Nucleic acid encoding an insecticidal protein toxin from photorhabdus |
Aug. 4, 2009 |
| 7569655 |
Biologically absorbable coatings for implantable devices based on polyesters and methods for fabricating the same |
Aug. 4, 2009 |
|
|
|
